RCE

0.00%

46.5¢ recce pharmaceuticals ltd

Look at the upside... more tests mean more news flow... & that s...

First 30 Last

Share
Profile

Follow
TradingHault

212 Posts.

6

06/06/18

22:47

Post #: 33545899
Share

Originally posted by Pussycat1975 ↑

You guys are far too focused on human trials.

It is time you really looked at what is required by the FDA and also look at previous Recce announcements.

Before human trials can start Recce must have been granted Investigational New Drug Status (IND). Recce used to talk about this but have lately dropped any reference to IND.

To obtain IND the FDA needs to be sure that the drug “Recce 327” has been subject to appropriate testing.

Appropriate testing involves the testing of the drug to be performed under GLP standards. See previous announcements a long time ago re schedule of tests. Recently did identify GLP tests it was going to do.

To date Recce have not released any data about it performing tests under GLP standards.

Why? Perhaps because these tests are very expensive and take a long time. Also I think that due to the real concern around existing antibiotics becoming less effective Recce were hoping for the FDA to lower their standards.

Obviously the meeting with the FDA reinforced the requirements of the FDA I.e. Recce needs to perform GLP tests. The results of these GLP tests together with other relevant information regarding the chemical characteristics of the drug, the drug production methodology will be the basis for Recce applying for IND status.

If Recce are awarded IND status they can then think about human trials.

The recent announcement says it will be several quarters before Recce can really look at human trials.

I think this means that Recce were told by the FDA they have a lot more tests to do (GLP tests)

If Recce hade done all the required tests of the FDA it would not take several quarters to get to the next step.

I think Recce’s announcements have been very vague.

We shareholders deserve a more detailed explanation of what is really happening!!!

Expand

Look at the upside... more tests mean more news flow... & that s good news for the RCE holders. Back to the Lab boys!

Last edited by TradingHault: 06/06/18

RCE Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

OAR

Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come

HMI

Global Lithium up 13% as it joins the ranks of battery metal players pivoting to gold

There are more pages in this discussion • 11 more messages in this thread...

First 30 Last

Add RCE (ASX) to my watchlist

(20min delay)
Last 46.5¢		Change 0.000(0.00%)		Mkt cap ! $118.1M

Open	High	Low	Value	Volume
46.5¢	46.5¢	46.5¢	$2.131K	4.582K

Buyers (Bids)

No.	Vol.	Price($)
1	1263	46.0¢

Sellers (Offers)

Price($)	Vol.	No.
46.5¢	11173	5

View Market Depth

No.	Vol.	Price($)
3	35701	0.510
1	2928	0.505
2	29692	0.500
1	30000	0.495
1	50000	0.490

Price($)	Vol.	No.
0.520	6981	1
0.525	27349	2
0.530	10000	1
0.545	1834	1
0.550	54490	2

Last trade - 12.38pm 04/12/2024 (20 minute delay)

RCE (ASX) Chart

Look at the upside... more tests mean more news flow... & that s...

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come

Global Lithium up 13% as it joins the ranks of battery metal players pivoting to gold

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Look at the upside... more tests mean more news flow... & that s...

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come

Global Lithium up 13% as it joins the ranks of battery metal players pivoting to gold

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News